BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30271949)

  • 1. PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma.
    Valanejad L; Cast A; Wright M; Bissig KD; Karns R; Weirauch MT; Timchenko N
    Commun Biol; 2018; 1():67. PubMed ID: 30271949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient-Derived Xenograft Models.
    Johnston ME; Rivas MP; Nicolle D; Gorse A; Gulati R; Kumbaji M; Weirauch MT; Bondoc A; Cairo S; Geller J; Tiao G; Timchenko N
    Hepatology; 2021 Oct; 74(4):2201-2215. PubMed ID: 34037269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma.
    Gulati R; Hanlon MA; Lutz M; Quitmeyer T; Geller J; Tiao G; Timchenko L; Timchenko N
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular signatures of aggressive pediatric liver cancer.
    Johnston ME; Timchenko N
    Arch Stem Cell Ther; 2021; 2(1):1-4. PubMed ID: 34447970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma.
    Gulati R; Lutz M; Hanlon M; Cast A; Karns R; Geller J; Bondoc A; Tiao G; Timchenko L; Timchenko NA
    Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecule Cjoc42 Improves Chemo-Sensitivity and Increases Levels of Tumor Suppressor Proteins in Hepatoblastoma Cells and in Mice by Inhibiting Oncogene Gankyrin.
    D'Souza AM; Cast A; Kumbaji M; Rivas M; Gulati R; Johnston M; Smithrud D; Geller J; Timchenko N
    Front Pharmacol; 2021; 12():580722. PubMed ID: 33746747
    [No Abstract]   [Full Text] [Related]  

  • 7. General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
    Lee H; El Jabbour T; Ainechi S; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon SH; Ali SM; Schrock A; Fabrizio D; Frampton G; Nazeer T; Miller VA; Stephens PJ; Ross JS
    Hum Pathol; 2017 Dec; 70():84-91. PubMed ID: 29079173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability.
    Ueda Y; Hiyama E; Kamimatsuse A; Kamei N; Ogura K; Sueda T
    J Pediatr Surg; 2011 Dec; 46(12):2221-7. PubMed ID: 22152854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.
    Takayasu H; Horie H; Hiyama E; Matsunaga T; Hayashi Y; Watanabe Y; Suita S; Kaneko M; Sasaki F; Hashizume K; Ozaki T; Furuuchi K; Tada M; Ohnuma N; Nakagawara A
    Clin Cancer Res; 2001 Apr; 7(4):901-8. PubMed ID: 11309340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
    Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
    JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
    Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
    Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression
    Indersie E; Hooks KB; Capdevielle C; Fabre M; Dugot-Senant N; Desplat A; Lepreux S; Merched A; Grosset CF; Hagedorn M
    Oncotarget; 2018 Mar; 9(22):16149-16162. PubMed ID: 29662633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Resolution Magic-Angle-Spinning NMR in Revealing Hepatoblastoma Hallmarks.
    Tasic L; Avramović N; Jadranin M; Quintero M; Stanisic D; Martins LG; Costa TBBC; Novak E; Odone V; Rivas M; Aguiar T; Carraro DM; Werneck da Cunha I; Lima da Costa CM; Maschietto M; Krepischi A
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.
    Martin KA; Lupey LN; Tempera I
    J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine needle aspiration cytology of hepatoblastoma: a study of 20 cases.
    Parikh B; Jojo A; Shah B; Bansal R; Trivedi P; Shah MJ
    Indian J Pathol Microbiol; 2005 Jul; 48(3):331-6. PubMed ID: 16761744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
    Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
    Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
    Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
    BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack.
    Scherbakov AM; Stefanova LB; Sorokin DV; Semina SE; Berstein LM; Krasil'nikov MA
    Exp Cell Res; 2013 Dec; 319(20):3150-9. PubMed ID: 23973669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.